No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.5x · 10Y median 0.6x · 50th percentile · as of Oct 6, 2026
Annual revenue · last 5 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:05:57.281Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) stock was $2.38 as of Oct 6, 2026, 10:04 AM EDT, up 3.48% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -98.8%
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China.
Household & Personal Products · Wuxi, JS
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
$1.26M
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BYAH | $1.78M | $2.38 | +3.48% | -98.78% | N/A | N/A | N/A |
| 2IBG | $1.78M | $0.98 | +3.16% | -94.23% | N/A | N/A | vs BYAH |
| 3IPST | $1.62M | $2.95 | -6.05% | -99.00% | N/A | N/A | vs BYAH |
| 4GSUN | $1.99M | $0.21 | -4.49% | -90.93% | N/A | N/A | vs BYAH |
| 5BIOT | $1.55M | $0.36 | -2.67% | N/A | N/A | N/A | vs BYAH |
| 6AMSS | $1.41M | $0.43 | +0.61% | N/A | N/A | N/A | vs BYAH |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$2.38
High
N/A
